Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC
Clinical trial NCT04613284 · UNKNOWN
Trial details
- NCT number
- NCT04613284
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-02-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.